Aimbiotech

1 known investors

AIM Biotech develops humanized 3D microfluidic organ-on-a-chip platforms (idenTx and organiX) and provides contract research services for drug discovery, immuno-oncology, and functional precision medicine. Its products and assays let pharmaceutical and academic researchers culture organoids, biopsies, and tissues in vivo-like conditions as an alternative to animal models.